PSA18 has wrapped up in Sydney, with the future of pharmacy firmly in sight as PSA presented the Pharmacists in 2023 Discussion Paper, a...

PSA has this week lodged two major submissions addressing pharmacist remuneration. The first is our response to the Medicare Benefits Schedule Review Taskforce, where...

Since 1 April, medicines crucial to those suffering from cancer, Parkinson’s and motor neurone disease have become available on the Pharmaceutical Benefits Scheme (PBS). The...

Australian prescription dispensing volume is lower, but spending on PBS medicines has increased in the past two years, according to the Australian Institute of...

How pharmacists can use their pharmacotherapy medication management expertise to support women with gestational diabetes.

Increased funding for pharmacists in aged care and rural and remote communities would save lives and improve health outcomes, PSA has argued in its...